Maintenance of efficacy and safety with continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: Final phase IIIb study results
2005 ◽
Vol 52
(3)
◽
pp. P1
Keyword(s):
Keyword(s):
2014 ◽
Vol 71
(3)
◽
pp. 484-492
◽
Keyword(s):
2021 ◽
Vol 85
(3)
◽
pp. AB59
Keyword(s):
2011 ◽
Vol 12
(3)
◽
pp. 191-201
◽
Keyword(s):
2016 ◽
Vol 31
(3)
◽
pp. 507-517
◽
Keyword(s):
2005 ◽
Vol 52
(3)
◽
pp. P195
Keyword(s):
2012 ◽
Vol 2012
◽
pp. 111-113
Keyword(s):
2005 ◽
Vol 52
(3)
◽
pp. P174
2010 ◽
Vol 37
(4)
◽
pp. 299-310
◽